Demand for implantable collamer lenses will increase through 2035, with myopia at 61.7% share of the indication segment in 2025. Hospitals held 46.9% share of the end user segment in 2025. The market was valued at USD 0.4 billion in 2025 and is projected to reach USD 1.3 billion by 2035.